Trial intelligence / Profile preview

Food effect on pharmacokinetics of oral voclosporin in healthy Japanese adult males

jRCT2071220014Phase 1Completed

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of voclosporin in lupus nephritis (LN) (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Primary PK endpoints. Started Jul 2022; status: completed.

02

Drugs

voclosporin
03

Conditions

lupus nephritis (LN)

Beyond the preview

Go deeper on jRCT2071220014.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2071220014.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call